PubMed

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.

Bateman E, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S.

Ann Intern Med. 2008 Jul 1;149(1):33-42. Epub 2008 Jun 3.PMID: 18523132 [PubMed - indexed for MEDLINE]Related articlesFree article

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006922. Review.PMID: 19588410 [PubMed - indexed for MEDLINE]Related articles

Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.

Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodriguez JA.

Pulm Pharmacol Ther. 2009 Feb;22(1):9-19. Epub 2008 Nov 5. Review.PMID: 19026757 [PubMed - indexed for MEDLINE]Related articles

Regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Cates MJ.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006363. Review.PMID: 18646149 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE.

Ann Intern Med. 2006 Jun 20;144(12):904-12. Epub 2006 Jun 5.PMID: 16754916 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review.PMID: 16235410 [PubMed - indexed for MEDLINE]Related articles

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.

Ni CM, Greenstone IR, Ducharme FM.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005307. Review.PMID: 15846751 [PubMed - indexed for MEDLINE]Related articles

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review.PMID: 16235409 [PubMed - indexed for MEDLINE]Related articles

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006924. Review.PMID: 19370661 [PubMed - indexed for MEDLINE]Related articles

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137. PMID: 15674901 [PubMed - indexed for MEDLINE]Related articles

Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.

Chan J, Hui RL, Spence MM.

J Manag Care Pharm. 2007 Jan-Feb;13(1):21-7.PMID: 17269833 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.

Walters EH, Gibson PG, Lasserson TJ, Walters JA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001385. Review.PMID: 17253458 [PubMed - indexed for MEDLINE]Related articles

Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.

Lyseng-Williamson KA, Plosker GL.

Pharmacoeconomics. 2003;21(13):951-89. Review.PMID: 12959627 [PubMed - indexed for MEDLINE]Related articles

Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.

Tee AK, Koh MS, Gibson PG, Lasserson TJ, Wilson AJ, Irving LB.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001281. Review.PMID: 17636663 [PubMed - indexed for MEDLINE]Related articles

Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.

Wang MT, Skrepnek GH, Armstrong E, Sherrill DL, Harris RB, Tsai CL, Malone DC.

Curr Med Res Opin. 2008 Mar;24(3):859-67. Epub 2008 Feb 8.PMID: 18267052 [PubMed - indexed for MEDLINE]Related articles

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.PMID: 18211118 [PubMed - indexed for MEDLINE]Related articles

Regular treatment with formoterol for chronic asthma: serious adverse events.

Cates CJ, Cates MJ, Lasserson TJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006923. Review.PMID: 18843738 [PubMed - indexed for MEDLINE]Related articles

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.

Chuchalin A, Jacques L, Frith L.

Clin Drug Investig. 2008;28(3):169-81.PMID: 18266402 [PubMed - indexed for MEDLINE]Related articles

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.PMID: 18485271 [PubMed - indexed for MEDLINE]Related articlesFree article